Research Interests
Although typically benign, tumours of the pituitary and adrenal glands are associated with increased morbidity and mortality (e.g. due to cardiometabolic dysfunction in acromegaly and Cushing’s syndrome; hypertension in primary aldosteronism). Quality of life is often significantly impaired (lower than for several common malignancies), and many patients require long-term (even life-long) medical therapy.
Our research is focussed on optimising the diagnosis and treatment of these conditions, to allow more patients to access specific, and potentially curative interventions (e.g. surgery, stereotactic radiosurgery, radiofrequency ablation) in a timely manner. For example, we have developed and introduced into routine clinical practice, novel PET imaging techniques, which are transforming the care of a subgroup of patients with pituitary and adrenal tumours – individuals previously deemed unsuitable for surgery and consigned to a lifetime of expensive/poorly tolerated medical treatment, are, in many instances, undergoing curative surgery.
In parallel studies, we perform detailed phenotyping of patients with (i) acromegaly, (ii) TSH-secreting pituitary adenomas and (iii) primary aldosteronism.
Together with Professor Chatterjee and Drs Moran, Oddy and Halsall, we also provide a UK national thyroid function test referral service, offering specialised clinical, biochemical, molecular and radiological phenotyping.
Our expertise is acknowledged through authorship of several recent international guidelines, including:
Pituitary Incidentaloma: Pituitary Society International Consensus Group. Nat Rev Endocrinol – in press.
Acromegaly: Acromegaly Consensus Group. Nat Rev Endocrinol – in press
Multiple endocrine neoplasia type 1 (MEN1): Delphi Expert Panel. Lancet Diabetes Endocrinol, 2025 PMID: 40523372
Genetic disorders of thyroid hormone transport, metabolism and action: European Thyroid Association Guideline Group. Eur Thyroid J. 2024 PMID:38963712
Acromegaly: Acromegaly Consensus Group. Pituitary, 2023 PMID: 37923946
AVP deficiency: Working Group for renaming Diabetes Insipidus. Eur J Endocrinol, 2022 PMID:36239119
Cushing’s Disease: Pituitary Society. Lancet Diabetes Endocrinol, 2021 PMID:34687601
Prolactinoma: Pituitary Society. Nat Rev Endocrinol, 2023 PMID:37670148
Traumatic Brain Injury: 2nd Lancet Neurology Commission on traumatic brain injury. Lancet Neurol, 2022 PMID:36183712
Group Members
Dr James MacFarlane, Clinical Fellow
Dr Sophie Howarth, Clinical Fellow
Dr Linus Haberbosch, Visiting Clinical Fellow
Mr D Gillett, Assistant Professor
Dr W Bashari, Honorary Consultant
Mr August Palma, Research Nurse
Research funding
BHF
MRC
NIHR
Cambridge Biomedical Research Centre